Who has invested in BioMap?

GGV Capital, Baidu Ventures are named among the investors backing BioMap.

BioMap Funding: $100M Raised, Series A (2021)

BioMap funding overview

BioMap is based in Beijing, China. BioMap has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for BioMap runs through 2021; nothing later has been disclosed. Investors on record include GGV Capital, Baidu Ventures. 2 distinct backers are named across the disclosed rounds.

BioMap at a glance

Total raised: $100M
Latest round: Series A
Latest round date: January 2021
Headquarters: Beijing, China
Notable investors: GGV Capital, Baidu Ventures

Frequently asked about BioMap funding

How much has BioMap raised?: BioMap has raised $100M in total disclosed funding across the rounds on record.
Who has invested in BioMap?: GGV Capital, Baidu Ventures are named among the investors backing BioMap.
What was the latest BioMap funding round?: The most recent disclosed round is a Series A, announced in January 2021.
Where is BioMap based?: BioMap is based in Beijing, China.
When did BioMap last raise?: The last disclosed BioMap round closed in January 2021 at Series A.

Totals shown for BioMap aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.

BioMap Funding: $100M Raised, Series A (2021)

BioMap funding overview

BioMap at a glance

Frequently asked about BioMap funding

Companies related to BioMap (35)

Browse related funding lists (7)